Tenax Therapeutics (TENX)
(Delayed Data from NSDQ)
$3.59 USD
+0.02 (0.42%)
Updated May 10, 2024 03:59 PM ET
After-Market: $3.58 -0.01 (-0.14%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Tenax Therapeutics, Inc. [TENX]
Reports for Purchase
Showing records 21 - 40 ( 47 total )
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Just Getting Stronger in the Field of Pulmonary Hypertension; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Published Results Provide Strong HELP for Advancing Levosimendan to Phase 3 Study
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Pipeline Expansion Includes Innovative Clinical Development Plan; Reit Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Acquisition of PHPM Expands Expertise and Presence in Pulmonary Hypertension; Reiterate Buy and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Initiating Coverage With a Buy Rating and $5 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: BERNARDINO V
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department
Company: Tenax Therapeutics, Inc.
Industry: Medical - Biomedical and Genetics
Provider: Zacks Investment Research
Analyst: Research Department